Search for Clinical Trial Results

Sponsored By

Coronavirus Infections - 23 Studies Found

Status Study
Withdrawn Study Name: SARS Coronavirus Vaccine (SARS-CoV)
Condition: Coronavirus (SARS-CoV)
Date: 2007-09-20
Interventions:
  • Drug: Aluminum hydroxide Adjuv
Completed Study Name: Seroprevalence of MERS-CoV IgG in Healthcare Workers
Condition: Coronavirus Infections
Date: 2015-07-06
Completed Study Name: A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
Condition: Severe Acute Respiratory Syndrome
Date: 2007-12-20
Interventions: Drug: Lopinavir / Ritonavir plus Ribavirin
Withdrawn Study Name: Evaluation and Treatment of Severe Acute Respiratory Syndrome (SARS)
Condition: Severe Acute Respiratory Syndrome
Date: 2003-11-14
Completed Study Name: Contamination During Removal of Two Different Personal Protective Systems
Condition: Severe Acute Respiratory Syndrome
Date: 2005-09-06
Interventions: Procedure: Powered Air purifying respirator
Withdrawn Study Name: SARS Survivor Evaluations
Condition: Coronavirus (SARS-CoV)
Date: 2007-08-30
Completed Study Name: Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers
Condition: Severe Acute Respiratory Syndrome
Date: 2005-09-16
Interventions: Drug: Alferon LDO
Completed Study Name: Investigating Severe Acute Respiratory Syndrome (SARS)
Condition: SARS Virus
Date: 2003-08-05
Recruiting Study Name: MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
Condition: Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Date: 2016-06-20
Interventions:
  • Drug: Combination of Lopinavir /Ritonavir and Interferon beta-1b

Active, not recruiting Study Name: Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults
Condition: Middle East Respiratory Syndrome Coronavirus
Date: 2016-05-28
Interventions:
  • Biological: SAB-301 SAB-301 is
Next >>>